What is PinPoint Testing?
PinPoint Testing specializes in the manufacturing of testing products and offers consulting services designed to optimize workflow solutions for analytical laboratories. The company distinguishes itself through its CLIA and ANAB-ISO/IEC 17025:2017 accredited clinical and forensic testing laboratory. Its product portfolio, notably the ToxBox, is engineered to enhance operational efficiency and elevate data quality through innovative design principles. PinPoint Testing caters to a diverse range of sectors, including forensic and clinical toxicology, forensic chemistry, industrial hygiene, food testing, and environmental analysis, positioning itself as a key player in laboratory solutions.
How much funding has PinPoint Testing raised?
PinPoint Testing has raised a total of $1.3M across 2 funding rounds:
Private Equity
$1.2M
Debt
$104K
Private Equity (2017): $1.2M, investors not publicly disclosed
Debt (2021): $104K led by PPP
Key Investors in PinPoint Testing
PPP
Public-Private Partnership
What's next for PinPoint Testing?
The recent major strategic investment suggests PinPoint Testing is poised for significant expansion and further innovation. This capital infusion is likely to fuel advancements in their product development, particularly in areas like the ToxBox, and potentially broaden their market reach within the analytical laboratory and testing services sector. The company's focus on enhancing workflow solutions and data quality, combined with its accredited laboratory status, positions it for continued growth and leadership in its specialized markets.
See full PinPoint Testing company page
